US patent 11041156 has been granted and is in the process of being registered covering the use of ATL1102 for mobilizing leukemia cells in the treatment of acute myeloid leukemia (AML) to 2036
- Forums
- ASX - By Stock
- PER
- Ann: Appendix 4E and Full Year Statutory Accounts
Ann: Appendix 4E and Full Year Statutory Accounts, page-11
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.001(1.27%) |
Mkt cap ! $82.94M |
Open | High | Low | Value | Volume |
8.0¢ | 8.3¢ | 7.9¢ | $461.5K | 5.711M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 844186 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 292500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 844186 | 0.080 |
8 | 506274 | 0.079 |
5 | 575000 | 0.078 |
8 | 1027327 | 0.077 |
4 | 346421 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 292500 | 1 |
0.083 | 30000 | 1 |
0.084 | 93750 | 1 |
0.085 | 187500 | 2 |
0.086 | 250000 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online